货号:GS40157
Cudarolimab (IBI101) is a fully humanized monoclonal antibody developed as an immunotherapeutic agent for cancer. Unlike agonist antibodies that activate the OX40 pathway, IBI101 is designed as an OX40 antagonist. Its primary mechanism is to block the co-stimulatory interaction between OX40 and its ligand, thereby modulating T-cell activity within the tumor microenvironment for potential anti-tumor effects.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯